Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Tube Formation Potential of BMSCs and USSCs in Response to HIF-1α Overexpression under Hypoxia

Tube Formation Potential of BMSCs and USSCs in Response to HIF-1α Overexpression under Hypoxia Despite numerous studies on therapeutic effects of mesenchymal stem cells on ischemic tissue regeneration, including angiogenesis, their mechanism of action remains ambiguous. Due to the scarce of investigations based on different stem cell sources with known inherent molecular differences, present study compare tube formation of Bone marrow Mesenchymal Stem Cells and Unrestricted Somatic Stem Cells with known reported different Hox gene expression profile in response to HIF-1α overexpression under hypoxia. This might shed light on some parameters for selection of more responsive source with improved therapeutic effects. Superior in vitro tube formation on Matrigel substratum has been observed by Unrestricted Somatic Stem Cells compared to Bone marrow Mesenchymal Stem Cells which might possibly be due to the discriminating molecular properties of stem cell sources. It may help choosing the appropriate stem cell type for a given therapeutic expectations and also suggests some potential targets for future genetic modification of stem cells. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cytology and Genetics Springer Journals

Tube Formation Potential of BMSCs and USSCs in Response to HIF-1α Overexpression under Hypoxia

Download PDF
9 pages

Loading next page...
 
/lp/springer_journal/tube-formation-potential-of-bmscs-and-usscs-in-response-to-hif-1-WCfrUk0kvy
Publisher
Springer Journals
Copyright
Copyright © 2018 by Allerton Press, Inc.
Subject
Biomedicine; Human Genetics
ISSN
0095-4527
eISSN
1934-9440
DOI
10.3103/S0095452718030064
Publisher site
See Article on Publisher Site

Abstract

Despite numerous studies on therapeutic effects of mesenchymal stem cells on ischemic tissue regeneration, including angiogenesis, their mechanism of action remains ambiguous. Due to the scarce of investigations based on different stem cell sources with known inherent molecular differences, present study compare tube formation of Bone marrow Mesenchymal Stem Cells and Unrestricted Somatic Stem Cells with known reported different Hox gene expression profile in response to HIF-1α overexpression under hypoxia. This might shed light on some parameters for selection of more responsive source with improved therapeutic effects. Superior in vitro tube formation on Matrigel substratum has been observed by Unrestricted Somatic Stem Cells compared to Bone marrow Mesenchymal Stem Cells which might possibly be due to the discriminating molecular properties of stem cell sources. It may help choosing the appropriate stem cell type for a given therapeutic expectations and also suggests some potential targets for future genetic modification of stem cells.

Journal

Cytology and Genetics – Springer Journals

Published: Jun 4, 2018

References

  • Cardiac failure, transplantation and donation: current perspectives
    Ashraf, O.; Sharif, H.
  • Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis
    Gilstrap, L.; Niehaus, E.; Malhotra, R.; Ton, V.K.; Watts, J.; Seldin, D.C.; Madsen, J.C.; Semigran, M.J.
  • Current cell-based strategies for whole kidney regeneration
    Poornejad, N.; Schaumann, L.B.; Buckmiller, E.M.; Roeder, B.L.; Cook, A.D.
  • Genetically modified cells in regenerative medicine and tissue engineering
    Sheyn, D.; Mizrahi, O.; Benjamin, S.; Gazit, Z.; Pelled, G.; Gazit, D.
  • HIF-1-alpha overexpression induces angiogenesis in mesenchymal stem cells
    Razban, V.; Lotfi, A.S.; Soleimani, M.; Ahmadi, H.; Massumi, M.; Khajeh, S.; Ghaedi, M.; Najavand, S.; Khoshde, A.
  • Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue
    Golpanian, S.; Wolf, A.; Hatzistergos, K.E.; Hare, J.M.
  • Beyond hit-and-run: stem cells leave a lasting memory
    Ng, K.S.; Kuncewicz, T.M.; Karp, J.M.
  • High yield generation of hepatocyte like cells from adipose derived stem cells
    Lotfi, A.S.; Khoshdel, A.; Soleimani, M.; Daliri, M.; Razban, V.; Adibi, B.
  • Tumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal stem cells for glioma therapy
    Zhang, X.; Yao, S.; Liu, C.; Jiang, Y.
  • Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels
    Zentilin, L.; Tafuro, S.; Zacchigna, S.; Arsic, N.; Pattarini, L.; Sinigaglia, M.; Giacca, M.
  • In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure
    Bortolotti, F.; Ukovich, L.; Razban, V.; Martinelli, V.; Ruozi, G.; Pelos, B.; Dore, F.; Giacca, M.; Zacchigna, S.
  • Characterization of regenerative phenotype of unrestricted somatic stem cells (USSC) from human umbilical cord blood (hUCB) by functional secretome analysis
    Schira, J.; Falkenberg, H.; Hendricks, M.; Waldera-Lupa, D.M.; Kögler, G.; Meyer, H.E.; Müller, H.W.; Stühler, K.
  • A comparison between osteogenic differentiation of human unrestricted somatic stem cells and mesenchymal stem cells from bone marrow and adipose tissue
    Shafiee, A.; Seyedjafari, E.; Soleimani, M.; Ahmadbeigi, N.; Dinarvand, P.; Ghaemi, N.
  • Strategies to direct angiogenesis within scaffolds for bone tissue engineering
    Harris, G.M.; Rutledge, K.; Cheng, Q.; Blanchette, J.; Jabbarzadeh, E.
  • Hypoxiainduced angiogenesis: good and evil
    Krock, B.L.; Skuli, N.; Simon, M.C.
  • HIF-1alpha pathway: role, regulation and intervention for cancer therapy
    Masoud, G.N.; Li, W.
  • Hypoxiainducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia
    Ziello, J.E.; Jovin, I.S.; Huang, Y.
  • The HOX Code as a “biological fingerprint” to distinguish functionally distinct stem cell populations derived from cord blood
    Liedtke, S.; Buchheiser, A.; Bosch, J.; Bosse, F.; Kruse, F.; Zhao, X.; Santourlidis, S.; Kögler, G.
  • Epigenetic marking prepares the human HOXA cluster for activation during differentiation of pluripotent cells
    Atkinson, S.P.; Koch, C.M.; Clelland, G.K.; Willcox, S.; Fowler, J.C.; Stewart, R.; Lako, M.; Dunham, I.; Armstrong, L.
  • Control of developmental regulators by Polycomb in human embryonic stem cells
    Lee, T.I.; Jenner, R.G.; Boyer, L.A.; Guenther, M.G.; Levine, S.S.; Kumar, R.M.; Chevalier, B.; Johnstone, S.E.; Cole, M.F.; Isono, K.; Koseki, H.; Fuchikami, T.; Abe, K.; Murray, H.L.; Zucker, J.P.; Yuan, B.; Bell, G.W.; Herbolsheimer, E.; Hannett, N.M.; Sun, K.; Odom, D.T.; Otte, A.P.; Volkert, T.L.; Bartel, D.P.; Melton, D.A.; Gifford, D.K.; Jaenisch, R.; Young, R.A.
  • A dermal HOX transcriptional program regulates site-specific epidermal fate
    Rinn, J.L.; Wang, J.K.; Allen, N.; Brugmann, S.A.; Mikels, A.J.; Liu, H.; Ridky, T.W.; Stadler, H.S.; Nusse, R.; Helms, J.A.; Chang, H.Y.
  • Engineered heparan sulfate-collagen IV surfaces improve human mesenchymal stem cells differentiation to functional hepatocyte-like cells
    Razban, V.; Khajeh, S.; Lotfi, A.S.; Mohsenifar, A.; Soleimani, M.; Khoshdel, A.; Hashemi, E.
  • HIF-1-alpha promotes glutamine-mediated redox homeostasis and glycogen-dependent bioenergetics to support postimplantation bone cell survival
    Stegen, S.; Gastel, N.; Eelen, G.; Ghesquière, B.; D’Anna, F.; Thienpont, B.; Goveia, J.; Torrekens, S.; Looveren, R.; Luyten, F.P.; Maxwell, P.H.; Wielockx, B.; Lambrechts, D.; Fendt, S.M.; Carmeliet, P.; Carmeliet, G.
  • Overexpression of HIF-1-alpha in mesenchymal stem cells affects cell-autonomous angiogenic and osteogenic parameters
    Lampert, F.M.; Kutscher, C.; Stark, G.B.; Finkenzeller, G.
  • Priming dental pulp stem cells with fibroblast growth factor-2 increases angiogenesis of implanted tissue-engineered constructs through hepatocyte growth factor and vascular endothelial growth factor secretion
    Gorin, C.; Rochefort, G.Y.; Bascetin, R.
  • Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization
    Semenza, G.L.
  • Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and angiopoietin-1
    Nakatsu, M.N.; Sainson, R.C.; Aoto, J.N.; Taylor, K.L.; Aitkenhead, M.; Pérez-del-Pulgar, S.; Carpenter, P.M.; Hughes, C.C.
  • Hepatocyte growth factor/c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury
    Trapp, T.; Kögler, G.; El-Khattouti, A.; Sorg, R.V.; Besselmann, M.; Föcking, M.; Bührle, C.P.; Trompeter, I.; Fischer, J.C.; Wernet, P.
  • Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction
    Zhao, L.; Liu, X.; Zhang, Y.; Liang, X.; Ding, Y.; Xu, Y.; Fang, Z.; Zhang, F.
  • Novel c-met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells
    Park, C.H.; Cho, S.Y.; Ha, J.D.; Jung, H.; Kim, H.R.; Lee, C.O.; Jang, I.Y.; Chae, C.H.; Lee, H.K.; Choi, S.U.
  • Regulation of HGF and c-MET interaction in normal ovary and ovarian cancer: importance of targeting c-MET and HGF interaction
    Kwon, Y.; Godwin, A.K.
  • Adult human neural crestderived cells for articular cartilage repair
    Pelttari, K.; Pippenger, B.; Mumme, M.; Feliciano, S.; Scotti, C.; Mainil-Varlet, P.; Procino, A.; Rechenberg, B.; Schwamborn, T.; Jakob, M.; Cillo, C.; Barbero, A.; Martin, I.
  • The effects of culture conditions on the functionality of efficiently obtained mesenchymal stromal cells from human cord blood
    Laitinen, A.; Lampinen, M.; Liedtke, S.; Kilpinen, L.; Kerkela, E.; Sarkanen, J.R.; Heinonen, T.; Kogler, G.; Laitinen, S.
  • Regeneration, repair and remembering identity: the three Rs of Hox gene expression
    Wang, K.C.; Helms, J.A.; Chang, H.Y.